Patents by Inventor Rico Wiegers

Rico Wiegers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080070259
    Abstract: This invention relates to newly identified polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides, to their use in therapy and in identifying compounds which may be stimulators and/or inhibitors which are useful in therapy, to antibodies specific to such peptides, and to production of such polypeptides and polynucleotides.
    Type: Application
    Filed: October 15, 2007
    Publication date: March 20, 2008
    Applicant: SOLVAY PHARMACEUTICALS B.V.
    Inventors: Willy Deleersnijder, Rico Wiegers, Michael Weske
  • Patent number: 7312321
    Abstract: This invention relates to newly identified polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides, to their use in therapy and in identifying compounds which may be stimulators and/or inhibitors which are useful in therapy, to antibodies specific to such peptides, and to production of such polypeptides and polynucleotides.
    Type: Grant
    Filed: February 7, 2007
    Date of Patent: December 25, 2007
    Assignee: Solvay Pharmaceuticals B.V.
    Inventors: Willy Deleersnijder, Rico Wiegers, Michael Weske
  • Publication number: 20070148688
    Abstract: This invention relates to newly identified polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides, to their use in therapy and in identifying compounds which may be stimulators and/or inhibitors which are useful in therapy, to antibodies specific to such peptides, and to production of such polypeptides and polynucleotides.
    Type: Application
    Filed: February 7, 2007
    Publication date: June 28, 2007
    Applicant: SOLVAY PHARMACEUTICALS B.V.
    Inventors: Willy Deleersnijder, Rico Wiegers, Michael Weske
  • Patent number: 7189525
    Abstract: This invention relates to newly identified polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides, to their use in therapy and in identifying compounds which may be stimulators and/or inhibitors which are useful in therapy, and to production of such polypeptides and polynucleotides.
    Type: Grant
    Filed: May 15, 2006
    Date of Patent: March 13, 2007
    Assignee: Solvay Pharmaceuticals B.V.
    Inventors: Willy Deleersnijder, Rico Wiegers, Michael Weske
  • Publication number: 20060205018
    Abstract: This invention relates to newly identified polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides, to their use in therapy and in identifying compounds which may be stimulators and/or inhibitors which are useful in therapy, and to production of such polypeptides and polynucleotides.
    Type: Application
    Filed: May 15, 2006
    Publication date: September 14, 2006
    Applicant: SOLVAY PHARMACEUTICALS B.V.
    Inventors: Willy Deleersnijder, Rico Wiegers, Michael Weske
  • Patent number: 7083965
    Abstract: This invention relates to newly identified polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides, to their use in therapy and in identifying compounds which may be stimulators and/or inhibitors which are useful in therapy, and to production of such polypeptides and polynucleotides.
    Type: Grant
    Filed: June 18, 2004
    Date of Patent: August 1, 2006
    Assignee: Solvay Pharmaceuticals B.V.
    Inventors: Willy Deleersnijder, Rico Wiegers, Michael Weske
  • Patent number: 6855532
    Abstract: This invention relates to newly identified polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides, to their use in therapy and in identifying compounds which may be stimulators and/or inhibitors which are useful in therapy, and to production of such polypeptides and polynucleotides.
    Type: Grant
    Filed: May 20, 2002
    Date of Patent: February 15, 2005
    Assignee: Solvay Pharmaceuticals B.V.
    Inventors: Willy Deleersnijder, Rico Wiegers, Michael Weske
  • Publication number: 20040224356
    Abstract: This invention relates to newly identified polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides, to their use in therapy and in identifying compounds which may be stimulators and/or inhibitors which are useful in therapy, and to production of such polypeptides and polynucleotides.
    Type: Application
    Filed: June 18, 2004
    Publication date: November 11, 2004
    Applicant: Solvay Pharmaceuticals B.V.
    Inventors: Willy Deleersnijder, Rico Wiegers, Michael Weske
  • Publication number: 20030180877
    Abstract: This invention relates to newly identified polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides, to their use in therapy and in identifying compounds which may be stimulators and/or inhibitors which are useful in therapy, and to production of such polypeptides and polynucleotides.
    Type: Application
    Filed: May 20, 2002
    Publication date: September 25, 2003
    Applicant: Solvay Pharmaceuticals B.V.
    Inventors: Willy Deleersnijder, Rico Wiegers, Michael Weske